Health
A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity – News-Medical.Net
As newer vaccines are being developed to combat the ongoing pandemic of coronavirus disease 2019 (COVID-19), targeting the pathogen, severe acute respiratory syndrome…
As newer vaccines are being developed to combat the ongoing pandemic of coronavirus disease 2019 (COVID-19), targeting the pathogen, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new preprint research paper posted to the bioRxiv* server describes a new subunit nanovaccine that appears to have robust immunogenicity and neutralizing activity.
New approaches to spike-based vaccines
Both the viral spike antigen and its receptor-binding domain (RBD), which elicit highly potent neutralizing…
-
General9 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
Noosa News12 hours agoSanta drops in for carols
-
General15 hours agoCritically endangered orchid thrives as NSW Mid North Coast cemetery provides habitat refuge
-
Business15 hours agoHow to turn small weekly savings into life-changing wealth with ASX shares